Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU Patients
Phase 2
Completed
- Conditions
- Acute Renal Failure
- Registration Number
- NCT01228123
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The mortality of acute renal failure (ARF) remains to be high (around 60-70%) despite manifold improvements in ICU care. At present, it is not clear if the method chosen for renal replacement therapy, i.e. intermittent haemodialysis (IHD) or continuous haemofiltration (CVVH), might impact on the outcome of these patients. For this purpose, a prospective randomised clinical study of the effect of continuous versus intermittent renal replacement therapy on the mortality and outcome of acute renal failure will be performed.
- Detailed Description
please see above
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 252
Inclusion Criteria
- all ICU patients requiring renal replacement therapy
Exclusion Criteria
- patient denies informed consent
- patient not requiring intensive care therapy
- kidney transplanted patients
- chronic renal failure (serum creatinine > 3mg/dl)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Survival at 2 weeks after RRT 2 weeks after RRT in follow-up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Charite University Medicine
🇩🇪Berlin, Germany
Charite University Medicine🇩🇪Berlin, Germany